Clinical Trials Browser

Interventional × Prostatic Neoplasms × tandutinib × Clear all

NCT00390468 2014-05-28

Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases

Phase 2 Completed

18 enrolled 5 charts

Neoplasm Metastasis, Pain, Prostatic Neoplasms